NMR study of xenotropic murine leukemia virus-related virus protease in a complex with amprenavir
- PMID: 22842568
- DOI: 10.1016/j.bbrc.2012.07.083
NMR study of xenotropic murine leukemia virus-related virus protease in a complex with amprenavir
Abstract
Xenotropic murine leukemia virus-related virus (XMRV) is a virus created through recombination of two murine leukemia proviruses under artificial conditions during the passage of human prostate cancer cells in athymic nude mice. The homodimeric protease (PR) of XMRV plays a critical role in the production of functional viral proteins and is a prerequisite for viral replication. We synthesized XMRV PR using the wheat germ cell-free expression system and carried out structural analysis of XMRV PR in a complex with an inhibitor, amprenavir (APV), by means of NMR. Five different combinatorially (15)N-labeled samples were prepared and backbone resonance assignments were made by applying Otting's method, with which the amino acid types of the [(1)H, (15)N] HSQC resonances were automatically identified using the five samples (Wu et al., 2006) [14]. A titration experiment involving APV revealed that one APV molecule binds to one XMRV PR dimer. For many residues, two distinct resonances were observed, which is thought to be due to the structural heterogeneity between the two protomers in the APV:XMRV PR=1:2 complex. PR residues at the interface with APV have been identified on the basis of chemical shift perturbation and identification of the intermolecular NOEs by means of filtered NOE experiments. Interestingly, chemical shift heterogeneity between the two protomers of XMRV PR has been observed not only at the interface with APV but also in regions apart from the interface. This indicates that the structural heterogeneity induced by the asymmetry of the binding of APV to the XMRV PR dimer is transmitted to distant regions. This is in contrast to the case of the APV:HIV-1 PR complex, in which the structural heterogeneity is only localized at the interface. Long-range transmission of the structural change identified for the XMRV PR complex might be utilized for the discovery of a new type of drug.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Molecular and enzymatic characterization of XMRV protease by a cell-free proteolytic analysis.J Proteomics. 2012 Aug 3;75(15):4863-73. doi: 10.1016/j.jprot.2012.05.047. Epub 2012 Jun 9. J Proteomics. 2012. PMID: 22687250
-
Inhibition of XMRV and HIV-1 proteases by pepstatin A and acetyl-pepstatin.FEBS J. 2012 Sep;279(17):3276-86. doi: 10.1111/j.1742-4658.2012.08714.x. Epub 2012 Aug 17. FEBS J. 2012. PMID: 22804908 Free PMC article.
-
Crystal structure of XMRV protease differs from the structures of other retropepsins.Nat Struct Mol Biol. 2011 Feb;18(2):227-9. doi: 10.1038/nsmb.1964. Epub 2011 Jan 23. Nat Struct Mol Biol. 2011. PMID: 21258323 Free PMC article.
-
Lack of evidence for a role of xenotropic murine leukemia virus-related virus in the pathogenesis of prostate cancer and/or chronic fatigue syndrome.Virus Res. 2012 Jul;167(1):1-7. doi: 10.1016/j.virusres.2012.04.004. Epub 2012 Apr 15. Virus Res. 2012. PMID: 22531412 Review.
-
Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome.Rev Med Virol. 2011 Jan;21(1):3-17. doi: 10.1002/rmv.673. Epub 2010 Nov 26. Rev Med Virol. 2011. PMID: 21294212 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials